Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathwaysFrancesca Bruzzese, Alfredo Budillon, Antonio Luciano et al.|Cell Death and Disease|2013Cited by 57